Feedback
Duchenne/Becker Muscular Dystrophy (DMD) Sequencing
2011153
Ordering Recommendation

Order ONLY if previous DMD gene deletion/duplication testing did not identify a causative variant. Recommended first-tier tests are DMD Deletion/Duplication with Reflex to Sequencing (2011241) or DMD Deletion/Duplication (2011235).

Mnemonic
DMD SEQ
Methodology
Massively Parallel Sequencing
Performed
Varies
Reported
2-4 weeks
New York DOH Approval Status
Specimens from New York clients will be sent out to a New York DOH approved laboratory, if possible.
Submit With Order
ARUP Consult®
Disease Topics
Specimen Required
Patient Preparation
 
Collect
Lavender (EDTA) or yellow (ACD Solution A or B). 
Specimen Preparation
Transport 3 mL whole blood. (Min: 1 mL) 
Storage/Transport Temperature
Refrigerated. 
Unacceptable Conditions
 
Remarks
 
Stability
Ambient: 72 hours; Refrigerated: 1 week; Frozen: Unacceptable 
Reference Interval
By report
Interpretive Data
Refer to report.

Counseling and informed consent are recommended for genetic testing. Consent forms are available online at www.aruplab.com.

Compliance Statement C: For human genetic inheritable conditions and mutations. This test was developed and its performance characteristics determined by ARUP Laboratories. The U. S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.

Counseling and informed consent are recommended for genetic testing. Consent forms are available online.

Note
Hotline History
View Hotline History
CPT Code(s)
81408
Components
Component Test Code*Component Chart NameLOINC
2011210DMD Sequencing Specimen31208-2
2011211DMD Sequencing Interpretation50626-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Agammaglobulinemia, panhypogammaglobulinemia, Hyper-IgM syndrome, HIGM syndrome, HIGM1, HIGM2, HIGM3
  • Anti-polysaccharide antibody deficiency, late-onset combined immunodeficiency
  • CD21, Lambda-5, NEMO, CD20, CD45
  • Common variable hypogammaglobulinemia, IgA deficiency, selective IgA deficiency; CVID, common variab
  • HIGM4, HIGM5, immunoglobulin class-switch deficiency, selective antibody deficiency
  • Late-onset immunoglobulin deficiency, B-cell deficiency, genetic antibody deficiency, TACI, BAFFR
  • Selective IgM deficiency, IgG deficiency, IgG subclass deficiency, hypogammaglobulinemia